8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-
CAS1379763-05-9
8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)- (CAS 1379763-05-9) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 1379763-05-9
Chemical Specifications
Identifiers
| CAS number | 1379763-05-9 |
|---|---|
| Product name | 8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)- |
| Chinese name | (3aS,3a'S,8aR,8a'R)-2,2'-(1-苯基丙烷-2,2-二基)双(8,8a-二氢-3aH-茚并[1,2-d]恶唑) |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-?
The CAS Registry Number of 8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)- is 1379763-05-9.
How can I request a quotation for 8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-?
Send an inquiry for 8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)- (CAS 1379763-05-9) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 8H-Indeno[1,2-d]oxazole, 2,2'-(1-methyl-2-phenylethylidene)bis[3a,8a-dihydro-, (3aS,3'aS,8aR,8'aR)-
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.